Publication: Role of Oral Nutritional Supplements Enriched with β-Hydroxy-β-Methylbutyrate in Maintaining Muscle Function and Improving Clinical Outcomes in Various Clinical Settings.
dc.contributor.author | Sanz-Paris, A | |
dc.contributor.author | Camprubi-Robles, M | |
dc.contributor.author | Lopez-Pedrosa, J M | |
dc.contributor.author | Pereira, S L | |
dc.contributor.author | Rueda, R | |
dc.contributor.author | Ballesteros-Pomar, M D | |
dc.contributor.author | Garcia Almeida, J M | |
dc.contributor.author | Cruz-Jentoft, A J | |
dc.date.accessioned | 2023-01-25T10:09:52Z | |
dc.date.available | 2023-01-25T10:09:52Z | |
dc.date.issued | 2018 | |
dc.description.abstract | Aging and disease-related malnutrition are well associated with loss of muscle mass and function. Muscle mass loss may lead to increased health complications and associated increase in health care costs, especially in hospitalized individuals. High protein oral nutritional supplements enriched with β-hydroxy-β-methylbutyrate (HP-ONS+HMB) have been suggested to provide benefits such as improving body composition, maintaining muscle mass and function and even decreasing mortality rates. The present review aimed to examine current evidence on the effect of HP-ONS+HMB on muscle-related clinical outcomes both in community and peri-hospitalization patients. Overall, current evidence suggests that therapeutic nutrition such as HP-ONS+HMB seems to be a promising tool to mitigate the decline in muscle mass and preserve muscle function, especially during hospital rehabilitation and recovery. | |
dc.identifier.doi | 10.1007/s12603-018-0995-7 | |
dc.identifier.essn | 1760-4788 | |
dc.identifier.pmc | PMC5984960 | |
dc.identifier.pmid | 29806855 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984960/pdf | |
dc.identifier.unpaywallURL | https://link.springer.com/content/pdf/10.1007%2Fs12603-018-0995-7.pdf | |
dc.identifier.uri | http://hdl.handle.net/10668/12512 | |
dc.issue.number | 6 | |
dc.journal.title | The journal of nutrition, health & aging | |
dc.journal.titleabbreviation | J Nutr Health Aging | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Virgen de la Victoria | |
dc.page.number | 664-675 | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Review | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | HMB | |
dc.subject | Sarcopenia | |
dc.subject | aging | |
dc.subject | disease | |
dc.subject | malnutrition | |
dc.subject | muscle wasting | |
dc.subject | oral nutritional supplements | |
dc.subject.mesh | Aging | |
dc.subject.mesh | Body Composition | |
dc.subject.mesh | Dietary Supplements | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Malnutrition | |
dc.subject.mesh | Muscle, Skeletal | |
dc.subject.mesh | Musculoskeletal Physiological Phenomena | |
dc.subject.mesh | Nutritional Status | |
dc.subject.mesh | Sarcopenia | |
dc.subject.mesh | Valerates | |
dc.title | Role of Oral Nutritional Supplements Enriched with β-Hydroxy-β-Methylbutyrate in Maintaining Muscle Function and Improving Clinical Outcomes in Various Clinical Settings. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 22 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1